Delayed neoadjuvant therapeutic response in rare giant pulmonary tumor: A case report

Primary pulmonary synovial sarcoma (PPSS) is an extremely rare intrathoracic soft tissue sarcoma, but there remains a notable absence of consensus guidelines for the diagnosis and treatment of these tumors. In this case, we reported a 35-year-old PPSS patient who received neoadjuvant chemotherapy co...

Full description

Saved in:
Bibliographic Details
Main Authors: Kai Zhang, Yuanyuan Wang, Yi Li
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Respiratory Medicine Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007125001066
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849245752221499392
author Kai Zhang
Yuanyuan Wang
Yi Li
author_facet Kai Zhang
Yuanyuan Wang
Yi Li
author_sort Kai Zhang
collection DOAJ
description Primary pulmonary synovial sarcoma (PPSS) is an extremely rare intrathoracic soft tissue sarcoma, but there remains a notable absence of consensus guidelines for the diagnosis and treatment of these tumors. In this case, we reported a 35-year-old PPSS patient who received neoadjuvant chemotherapy consisting of adriamycin and ifosfamide combined with anlotinib, a multi-target tyrosine kinase inhibitor. Although initial response assessment was not encouraging, subsequent imaging studies revealed therapeutic efficacy. This case underscores the critical role of multidisciplinary team and neoadjuvant therapy in PPSS management, aiming to raise awareness of this rare malignancy.
format Article
id doaj-art-d751741f2efb4181bfde8d9c58b93a42
institution Kabale University
issn 2213-0071
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Respiratory Medicine Case Reports
spelling doaj-art-d751741f2efb4181bfde8d9c58b93a422025-08-20T03:58:41ZengElsevierRespiratory Medicine Case Reports2213-00712025-01-015710227010.1016/j.rmcr.2025.102270Delayed neoadjuvant therapeutic response in rare giant pulmonary tumor: A case reportKai Zhang0Yuanyuan Wang1Yi Li2Department of Oncology, 920th Hospital of Joint Logistics Support Force, Kunming, ChinaDepartment of Pathology, 920th Hospital of Joint Logistics Support Force, Kunming, ChinaDepartment of Oncology, 920th Hospital of Joint Logistics Support Force, Kunming, China; Corresponding author.Primary pulmonary synovial sarcoma (PPSS) is an extremely rare intrathoracic soft tissue sarcoma, but there remains a notable absence of consensus guidelines for the diagnosis and treatment of these tumors. In this case, we reported a 35-year-old PPSS patient who received neoadjuvant chemotherapy consisting of adriamycin and ifosfamide combined with anlotinib, a multi-target tyrosine kinase inhibitor. Although initial response assessment was not encouraging, subsequent imaging studies revealed therapeutic efficacy. This case underscores the critical role of multidisciplinary team and neoadjuvant therapy in PPSS management, aiming to raise awareness of this rare malignancy.http://www.sciencedirect.com/science/article/pii/S2213007125001066
spellingShingle Kai Zhang
Yuanyuan Wang
Yi Li
Delayed neoadjuvant therapeutic response in rare giant pulmonary tumor: A case report
Respiratory Medicine Case Reports
title Delayed neoadjuvant therapeutic response in rare giant pulmonary tumor: A case report
title_full Delayed neoadjuvant therapeutic response in rare giant pulmonary tumor: A case report
title_fullStr Delayed neoadjuvant therapeutic response in rare giant pulmonary tumor: A case report
title_full_unstemmed Delayed neoadjuvant therapeutic response in rare giant pulmonary tumor: A case report
title_short Delayed neoadjuvant therapeutic response in rare giant pulmonary tumor: A case report
title_sort delayed neoadjuvant therapeutic response in rare giant pulmonary tumor a case report
url http://www.sciencedirect.com/science/article/pii/S2213007125001066
work_keys_str_mv AT kaizhang delayedneoadjuvanttherapeuticresponseinraregiantpulmonarytumoracasereport
AT yuanyuanwang delayedneoadjuvanttherapeuticresponseinraregiantpulmonarytumoracasereport
AT yili delayedneoadjuvanttherapeuticresponseinraregiantpulmonarytumoracasereport